The data on Epinephrine for breakthrough in refractory respiratory distress isn't overly compelling. But this abstract provides a look as to whether it's effective, whether it's more or less effective than Terbutaline, and whether removing the barriers to giving either one increased their benefit. How did they both fare? ***These abstracts have not been published or peer reviewed yet*** #EMS #EMTs #Paramedics #firstresponders #naemsp2026 | EMS Avenger